Victory to Ukraine
Joined May 2008
- Tweets 3,046
- Following 714
- Followers 1,050
- Likes 5,973
89 Photos and videos
Pinned Tweet
11 Mar 2025
Find me anywhere other than here. bsky.app/profile/herrison200…
threads.net/@herrison2000
89
Feb 23
1/5 My PhD thesis has finally been posted. I spent time looking at #altmetrics and citation rates of #openaccess vs non-oa research. There are several findings: firstly, the 'advantage' is very (very) different per discipline and metric doi.org/10.23912/open_access…
1
1
1
71
Feb 23
4/5 Fourth. Green is rarer than Gold OA, hasn't grown, narrow disciplinery range, tends to outperform Gold. I wouldn't bother publishing in new/lower Gold journals, personal opinion. Paper in bits on dining room table. tinyurl.com/4vxvaax9 doi.org/10.23912/open_access…
1
13
Feb 23
5/5 Bonus post. I think the history of scientific revolutions, and the application of theory are worth a read. Might even raise a chuckle. Download here tinyurl.com/4vxvaax9 doi.org/10.23912/open_access… #fucktrump #fuckmusk Sorry, but won't reply here. Bluesky :)
19
7 Nov 2024
Two weeks ago, @CarrieBrubaker, @C_Areia recorded a pod for MAPS about 'interesting' research in the pharma space. I picked 2 articles about TB, which kills millions. A new drug nature.com/articles/s41591-0… and @herorats medicalaffairs.org/top-10-mo…
1
1
2
151
9 Oct 2024
I am continuing to be proud of supporting @herorats and urge people to check out doi.org/10.1186/s12879-024-0… Rats are amazingly fast and accurate when it comes to diagnosing TB
67
Mike Taylor retweeted
5 Aug 2024
Put simply: If you engage in violent protests, you will face the full force of the law.
ALT Graphic with text that reads: Prison sentences for: Rioting: up to 10 years Violent disorder: up to 5 years Inciting racial hatred: up to 7 years Criminal damage: up to 10 years
12,516
5,139
16,474
6,640,544
Mike Taylor retweeted
1 Aug 2024
Hear @digitalsci's Head of Data Insights, Mike Taylor (@herrison), in this new podcast hosted by @MAPSmedaffairs: "Maximizing the Impact of a Niche Publication".
🔊 Listen to the podcast or see a transcript: ow.ly/TtuW50SP2wK
@altmetric #MedAffairs #MedicalAffairs
2
5
305
21 Jul 2024
Ground breaking study that continues to show that using celebrities as case studies and subjects boosts public engagement with research @C_Areia
taylorfrancis.com/chapters/e…
1
1
3
143
5 Jul 2024
I reckon I'll see another referendum in my life time, but it'll be in NI not Scotland @sinnfeinireland
75
24 Jun 2024
Since I'm writing the follow-up paper, thought I ought to post the last one :) while I wait (and wait) on peer review arxiv.org/abs/2406.10535 Turns out the #oa advantage is super complex (stay tuned for a second paper this summer)
1
1
102
17 Jun 2024
The grief I get for having mildly entertaining titles for my research, and then this... pearl turns up link.springer.com/article/10…
47
Mike Taylor retweeted
🚨Reform is NOT a political party🚨
3 Jun 2024
A gentle reminder that Reform UK is not a democratic political party. It is a private company owned 53% by Nigel Farage & 33% by Richard Tice. It has no real members; it has no democratic policy-making processes. It is an unaccountable entity & play thing of two rich men. Via @FT
13
194
407
48,250
Mike Taylor retweeted
31 May 2024
So which ALK inhibitor is best in class ? Who gets the CROWN at the 5 years follow up ? Lorlatinib vs Crizotinib. Lorlatinib PFS HR 0.24 for pts without Brain mets . Median PFS not reached . HR of 0.08 for those with brain mets . Clearly Lorlatinib is winner . @ASCO #ASCO24 @OncoAlert @OncBrothers @Larvol @brunolarvol
2
8
45
8,283
Mike Taylor retweeted
31 May 2024
So, 5y PFS is out. CROWN shows that only 3% of patients had disease progression from year 4 to year 5. Toxic, Lorlatinib is indeed, but this in totally unprecedented in thoracic oncology. ALK fusion patients leading the way into making NSCLC a chronic disease #ASCO24
1
30
96
30,580